3-(5,6-dimethoxybenzimidazol-2-ylidene)-1,2-dihydropyrazol-4-amine structure
|
Common Name | 3-(5,6-dimethoxybenzimidazol-2-ylidene)-1,2-dihydropyrazol-4-amine | ||
|---|---|---|---|---|
| CAS Number | 825619-32-7 | Molecular Weight | 259.26400 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C12H13N5O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | 3-(5,6-dimethoxybenzimidazol-2-ylidene)-1,2-dihydropyrazol-4-amine |
|---|---|
| Synonym | More Synonyms |
| Molecular Formula | C12H13N5O2 |
|---|---|
| Molecular Weight | 259.26400 |
| Exact Mass | 259.10700 |
| PSA | 100.78000 |
| InChIKey | DBBISNXINKUTSJ-UHFFFAOYSA-N |
| SMILES | COc1cc2nc(-c3[nH]ncc3N)[nH]c2cc1OC |
|
~53%
3-(5,6-dimethox... CAS#:825619-32-7 |
| Literature: ASTEX THERAPEUTICS LIMITED Patent: WO2007/77435 A1, 2007 ; Location in patent: Page/Page column 211 ; WO 2007/077435 A1 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| 1H-Pyrazol-4-amine,3-(5,6-dimethoxy-1H-benzimidazol-2-yl) |
| 3-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-ylamine |
| 3-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazole-4-ylamine |